Omeros Corporation

NASDAQ:OMER

Biotechnology

Healthcare
$14.55 +4.46%

+$0.43 today

Market cap
$1.08B
Beta
2.53
P/E (TTM)
8.4
EPS (TTM)
$1.20
52W Low $2.95High $17.65

Volume 2.53M

Average 1.55M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$116.09M

FY 2025 · Annual

Investing Cash Flow

$164.52M

FY 2025 · Annual

+100.1% YoY

Financing Cash Flow

-$42.17M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(191.55M)(182.03M)(117.81M)(156.82M)(3.35M)
Depreciation & Amortization1.39M952K920K950K964K
Deferred Income Tax00000
Stock-Based Compensation0011.65M10.49M8.19M
Change in Working Capital(14.11M)(118.97M)247.42M29.74M33.72M
Accounts Receivables(34.31M)(175.07M)245.72M40.01M30.45M
Inventory00000
Accounts Payables14.64M(10.67M)000
Other Working Capital5.57M66.76M1.7M(10.27M)3.27M
Other Non-Cash Items94.54M213.56M(67.46M)(33.17M)(155.62M)
Operating Cash Flow(109.72M)(86.48M)74.73M(148.8M)(116.09M)
Capital Expenditures(277K)(113K)(426K)(165K)(65K)
Acquisitions (Net)125.99M0000
Purchases of Investments(32.01M)(429.05M)(1.02B)(987.39M)(185.31M)
Sales of Investments100M301.59M1.05B1.07B109.9M
Other Investing Activities0000240M
Investing Cash Flow193.71M(127.56M)27.45M82.22M164.52M
Debt Repayment(1.82M)123.83M(101.58M)(41.34M)(89.16M)
Common Stock Issued8.38M415K0046.99M
Common Stock Repurchased00(4.65M)(11.85M)0
Dividends Paid00000
Other Financing Activities(241K)0150K116.07M0
Financing Cash Flow6.32M124.25M(106.08M)62.88M(42.17M)
Effect of Forex Changes00000
Net Change in Cash90.31M(89.8M)(3.9M)(3.71M)6.26M
Free Cash Flow(110M)(86.6M)74.3M(148.97M)(116.16M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$3.4M
+ D&A$964.0K
+ Stock-Based Comp$8.2M
+ Deferred Tax$0
+ Working Capital$33.7M
- Other Non-Cash-$155.6M
= Operating Cash Flow-$116.1M
- Capex-$65.0K
= Free Cash Flow-$116.2M

Analysis

FY2025 free cash flow is -$116.2M. FCF conversion is 3467.4% of net income. Operating cash flow was -$116.1M, with capex of -$65.0K. The largest bridge item is Other Non-Cash at -$155.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipSep 24, 2026
4Statement of changes in beneficial ownershipSep 1, 2026
4Statement of changes in beneficial ownershipAug 28, 2026

Does OMER generate free cash flow?

Omeros Corporation (OMER) generated -$116.16M of free cash flow in fiscal 2025.

How much operating cash flow does OMER produce?

Operating cash flow was -$116.09M, before capital expenditures of $65,000.00.